Regulus reports mixed results in early-stage trial for polycystic kidney disease
22 May 2021 - 1:51AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Regulus Therapeutics (NASDAQ:RGLS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Regulus Therapeutics (NASDAQ:RGLS)
Historical Stock Chart
From Apr 2023 to Apr 2024